Oncology

Top Story

FDA approves Braftovi with Erbitux for metastatic colorectal cancer subset

FDA approves Braftovi with Erbitux for metastatic colorectal cancer subset
April 9, 2020
In the Journals

Blood test detects dozens of cancer types, often before symptoms emerge

March 31, 2020
A novel blood test accurately detected more than 50 types of cancer with a specificity of 99.3%, according to results of the prospective Circulating Cell-free Genome…

Nine important updates in colorectal cancer

March 28, 2020
Colorectal Cancer Awareness Month is observed in March. The observance is intended to increase awareness about the prevalence of the disease, its symptoms, and the key…
In the JournalsPerspective

Colon cancer relapse, death more common among children, young adults

March 27, 2020
Individuals aged 25 years and younger with colon cancer appeared to be at higher risk for relapse and death than their older adults, according to data published in…
More Headlines »